Activity Preview


AF Summit 2018

Activity Type:

  • Course

Release Date: 10/1/2018

Expiration Date: 9/30/2019

  • CME: 4.75
  • Participation - no CE credit: 4.75


The 2018 AF Summit program provides a comprehensive review of atrial fibrillation (AF) ablation and evolving therapies that are shaping the field. 

Earn up to 4.5 CME credits 

AF01. Beyond PV Isolation for Persistent AF: What is the Answer?
Session Description: This session will review novel approaches to ablation of persistent AF, as well as, a presentation by the recipient of the Lectureship Award, Fred Morady, “My Perspective on Catheter Ablation of Persistent AF”.

AF02. New and Old Technologies for AF Ablation
Session Description: This session will provide an update on techniques and outcomes of AF ablation of persistent and long standing persistent atrial fibrillation.

AF03. More Unmet Challenges When it Comes to AF Ablation
Session Description: This session will center evolving areas in AF ablation incorporating risk modification, management of anticoagulants, and focus on best practice methods of AF ablation.


Learning Objectives

Upon completion of this educational activity, participants will be able to:

  1. Analyze the STAR AF Trial and how it has impacted the field
  2. Understand the implications of the Fire and Ice Trial
  3. Evaluate new tools and technologies that may impact the field
  4. Explain the scientific basis of persistent AF
  5. Assess non PV approaches
  6. Discuss how to maximize PV isolation
  7. Describe the role of risk factor modification
  8. Identify the role of AF ablation in asymptomatic patients
  9. Recognize when to say "No go" to AF ablation

Access Activity

Target Audience

Clinical Cardiac EPs
Allied Professionals
Directors of EP Labs
EP Fellows


Faculty -

Hugh Calkins, MD, FHRS, CCDS
Johns Hopkins Hospital, Baltimore

Jeremy N. Ruskin, MD
Massachusetts General Hospital

Pierre Jais, MD
Hôpital Haut-Lévêque, Bordeaux

Douglas L. Packer, MD, FHRS
Mayo Clinic - St. Mary's Hospital,

Ulrich Schotten, MD, PhD
University of Maastricht

Vivek Y. Reddy, MD
Icahn School of Medicine at Mount Sinai

Shih-Ann Chen, MD
Taipei Veterans General Hospital

Albert L. Waldo, MD, FHRS, CCDS
Case Western Reserve Univ, University Hospitals of Cleveland

Andrea Natale, MD, FHRS
Texas Cardiac Arrhythmia Institute at St. David's Medical Center

Gerhard Hindricks, MD
Heart Center - University of Leipzig

Ellen Hoffmann, MD
Stadtisches Klinikum Munchen GmbH

D. Wyn Davies, MD, FHRS

David J. Callans, MD, FHRS, CCDS
Hospital of the Univ of Pennsylvania

CME Information

The Heart Rhythm Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Heart Rhythm Society designates this enduring material for a maximum of 4.75 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The AMA has determined that physicians not licensed in the United States who participate in this CME activity are eligible for AMA PRA Category 1 Credit™.




It is the policy of the Heart Rhythm Society to ensure balance, independent objectivity, and scientific rigor in all its certified educational activities. Everyone involved in the planning and participation of continuing medical education activities is required to disclose any real or apparent conflicts of interest related to the content in his/her presentation(s) and also disclose discussions of unlabeled/unapproved uses of drugs or devices during his/her presentation(s).

Faculty Disclosures

Faculty -

Hugh Calkins, MD, FHRS, CCDS 
Compensation for Services: Abbott Laboratories, AtriCure, Inc., Toray Industries Inc. St. Jude Medical, Boehringer Ingelheim, Medtronic, Inc.
Research Grant: Medtronic, Inc, Boston Scientific Corp

Jeremy N. Ruskin, MD 
Compensation for Services: Acesion Pharma, Mediasphere Medical, InCarda Therapeutics Pfizer, Inc., Lantheus Medical Imaging, Cala Health, Gilead Sciences, Inc. , Apple, Inc., Johnson and Johnson, Jazz Pharmaceuticals, Advanced Medical Education
Stock Options - Non-Public/Public: Element Science, Inc, InfoBionic, NewPace Ltd., Portola Pharmaceuticals Inc.

Pierre Jais, MD
Compensation for Services: Biosense Webster, Inc., Boston Scientific Corp., St. Jude Medical, Luxcath, Iowa Approach Incorporated
Stock Options - Non-Public/Public: Iowa Approach Incorporated, Affera

Douglas L. Packer, MD, FHRS 
Compensation for Services: Abbott Laboratories Aperture Diagnostics Biosense Webster, Inc., Boston Scientific Corp., CardioFocus, Inc., CardioInsight Technologies Johnson and Johnson Medtronic, Inc., SIEMENS, St. Jude Medical, Topera Medical, Thermedical, Mediasphere Medical
Royalty Income: Wiley-Blackwell, St. Jude Medical.
Research Grant: Endosense, SIEMENS, Hansen Medical, Boston Scientific Corp., CardioFocus, Inc., American Heart Association, CardioInsight Technologies, Thermedical, Biosense Webster, Inc., NIH, Medtronic Inc., St. Jude Medical
Other: Medtronic, Inc., St. Jude Medical, CardioInsight Technologies, Medtelligence, Biosense Webster, Inc

Ulrich Schotten, MD, PhD 
Compensation for Services: Roche Diagnostics
Research Grant: Roche Diagnostics, Medtronic, Inc.

Vivek Y. Reddy, MD
Compensation for Services: Medtronic, Inc., Biotronik, CardioFocus, Inc., Impulse Dynamics USA, EBR Systems, ACT, Boston Scientific Corp., Biosense Webster, Inc., Abbott Vascular, Iowa Approach Incorporated, VytronUS, Inc.
Stock Options - Non-Public/Public: Acutus Medical Inc, Luxcath, Corvia Medical, EpiEP, Affera, VytronUS, Inc., Iowa Approach Incorporated, BackBeat, BioSig Technologies, AFTX, Apama Medical, CardioNXT, Circa Scientific, Cibiem, Javelin, Manual Surgical Sciences, Autonomix Inc, Axon Therapies Inc, East End Medical Inc, EP Dynamics, Epix Therapeutics Inc, Medlumics Inc., Surecor, Inc.
Research Grant: Biosense Webster, Inc., St. Jude Medical, Boston Scientific Corp., CardioFocus, Inc.

Shih-Ann Chen, MD
Compensation for Services: Medtronic, Inc., Boehringer Ingelheim, Bayer / Schering Pharma, St. Jude Medical, Sanofi Aventis
Research Grant: Biosense Webster, Inc., Boston Scientific Corp., CPMC, St. Jude Medica
Speaker/Honoraria: Bayer / Schering Pharma

Albert L. Waldo, MD, FHRS, CCDS
Compensation for Services: AtriCure, Inc., Milestone, Biosense Webster, Inc.
Research Grant: Gilead Sciences, Inc.
Speaker/Honoraria: Bristol Meyers Squibb & Pfizer, Inc

Andrea Natale, MD, FHRS
Compensation for Services: Boston Scientific Corp. St. Jude Medical Medtronic, Inc., Janssen Pharmaceuticals, Biosense Webster, Inc.

Gerhard Hindricks, MD 
Research Grant: Abbott, Boston Scientific Corp.

Ellen Hoffmann, MD
Research Grant: St. Jude Medical, Biotronik, Edwards Lifesciences, Medtronic, Inc.
Speaker/Honoraria: Boston Scientific Corp., Boehringer Ingelheim

D. Wyn Davies, MD, FHRS
Compensation for Services: Medtronic, Inc.

David J. Callans, MD, FHRS, CCDS 
Compensation for Services: Impulse Dynamics USA, Biotronik, Medtronic, Inc., Abbott Vascular, St. Jude Medical, Acutus Medical Inc., Boston Scientific Corp.
Research Grant: National Institutes for Health

Isabel Deisenhofer, MD
Speaker/Honoraria: Biosense Webster, Inc., St. Jude Medical

Chloe Thomas - Nothing to Disclose

Russell Werlinich - Nothing to Disclose



Allegations of conflict of interest and bias are taken seriously and are investigated by the Ethics Oversight Committee, Scientific Sessions Program Committee and/or the Education Committee. Your complaint will be referred to the appropriate committee, and you will be informed in writing of the outcome of its review and decision. Submit a confidential complaint by completing the form at or submit an email message to

Access Activity